A general drug reference post pointing to tirzepatide basics like interactions and warnings. Evergreen material with no new development behind it.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Compounds modeled on the weight loss blockbusters are also in trials for schizophrenia and Parkinson's disease, among other brain conditions.
A Medscape opinion roundup asks whether microdosing tirzepatide carries too much risk and whether surgery still matters, plus why sweet-and-salty snacks hook us.
Loading…